Skip to main content
. 2018 Jan 17;51(2):e12434. doi: 10.1111/cpr.12434

Figure 3.

Figure 3

DFO improved in vitro migration of BMSCs to SDF‐1. This treatment effect was blocked by AMD3100 or LY294002. In control group, no SDF‐1 was applied to the MSCs. SDF‐1, stromal cell‐derived factor‐1; BMSCs, bone marrow mesenchymal stem cells. *P < .001 compared to non‐treated MSCs group; # P < .001 compared to the DFO group (One‐way ANOVA)